Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.

Search TravelDoctorOnline

Authors: Njogu J,Akhwale W,Hamer DH,Zurovac D,
Address: Malaria Public Health and Epidemiology Group, KEMRI/Wellcome Trust Research Programme, P.O. Box 43640-00100, Nairobi, Kenya.
Journal: East Afr Med J.


Publication: 2008 May;85(5):213-21.

abstract

OBJECTIVE:

To evaluate health facility and health worker readiness to deliver new artemether-lumefantrine (AL) treatment policy for uncomplicated malaria in Kenya.

DESIGN:

Cross-sectional survey.

SETTING:

Health facilities in four sentinel districts in Kenya.

PARTICIPANTS:

All government facilities in study districts (n = 211) and all health workers performing outpatient consultations (n = 654).

MAIN OUTCOME MEASURES:

Availability of antimalarial drugs on the survey day, stock-outs in past six months, presence of AL wall charts, health worker's exposure to in-service training on AL and access to new national malaria guidelines.

RESULTS:

The availability of any tablets of AL, sulfadoxine-pyrimethamine and amodiaquine was nearly universal on the survey day. However, only 61% of facilities stocked all four weight-specific packs of AL. In the past six months, 67% of facilities had stock-out of at least one AL tablet pack and 15% were out of stock for all four packs at the same time. Duration of stock-out was substantial for all AL packs (median range: 27-39% of time). During the same period, the stock-outs of sulfadoxine-pyrimethamine and amodiaquine were rare. Only 19% of facilities had all AL wall charts displayed, AL in-service training was provided to 47% of health workers and 59% had access to the new guidelines.

CONCLUSION:

Health facility and health worker readiness to implement AL policy is not yet optimal. Continuous supply of all four AL pack sizes and removal of not recommended antimalarials is needed. Further coordinated efforts through the routine programmatic activities are necessary to improve delivery of AL at the point of care.



Related Articles
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Trop Med Int Health. 2008
Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW. Trop Med Int Health. 2008 Jan; 13(1):99-107.
The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
Malar J. 2012
The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
Sudoi RK, Githinji S, Nyandigisi A, Muturi A, Snow RW, Zurovac D. Malar J. 2012 Feb 8; 11:37. Epub 2012 Feb 8.
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Malar J. 2007
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW. Malar J. 2007 Mar 16; 6:31. Epub 2007 Mar 16.
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Cochrane Database Syst Rev. 2009
Review Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D, Zani B, Donegan S, Olliaro P, Garner P. Cochrane Database Syst Rev. 2009 Jul 8; (3):CD007483. Epub 2009 Jul 8.
Review Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.
Cochrane Database Syst Rev. 2005
Review Artemether-lumefantrine (six-dose regimen) for treating uncomplicated falciparum malaria.
Omari AA, Gamble C, Garner P. Cochrane Database Syst Rev. 2005 Oct 19; (4):CD005564. Epub 2005 Oct 19.
Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
Malar J. 2012
Provider knowledge of treatment policy and dosing regimen with artemether-lumefantrine and quinine in malaria-endemic areas of western Kenya.
Watsierah CA, Onyango RO, Ombaka JH, Abong'o BO, Ouma C. Malar J. 2012 Dec 29; 11:436. Epub 2012 Dec 29.
Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania.
Risk Manag Healthc Policy. 2011
Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania.
Mugoyela V, Minzi O. Risk Manag Healthc Policy. 2011; 4:89-95. Epub 2011 Sep 6.
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.
Malar J. 2011
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya.
Lawford H, Zurovac D, O'Reilly L, Hoibak S, Cowley A, Munga S, Vulule J, Juma E, Snow RW, Allan R. Malar J. 2011 Sep 23; 10:281. Epub 2011 Sep 23.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.